Efficacy and safety of trametinib in neurofibromatosis type 1-associated plexiform neurofibroma and low-grade glioma: a systematic review and meta-analysis

HIGHLIGHTS

  • who: Dun Wang and colleagues from the Department of Plastic and Reconstructive Surgery, Shanghai Ninth People`s Hospital, Shanghai Jiao Tong Department of Burn and Plastic Surgery, West China Hospital of Sichuan University, No , Wainan Guoxue have published the paper: Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis, in the Journal: Pharmaceuticals 2022, 956 of /2022/
  • what: The results yielded in this systematic review and meta-analysis showed that trametinib significantly controlled the tumor progression of NF1-related pNF and LGG . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?